TypeName: Business Offer
Country: Afghanistan
Summary: Crisaborole is a novel PDE-4 inhibitor used as a nonsteroidal topical medication for the treatment of mild-to-moderate atopic dermatitis (eczema). Crisaborole selectively inhibits PDE-4B which mainly leads to inflammation. Tumor necrosis factor alpha (TNFα), interleukin-12 (IL-12), IL-23 and other cytokines are also suppressed while crisaborole functioning.https://www.bocsci.com/crisaborole-cas-906673-24-3-item-426762.html
Description: [RequestDescription]
OfferId: 2683
Name:Alex Brown
Telphone: